“…Peak plasma levels are 1.2 lg mL À1 for every mg of an oral dose, reached within 2-3 h. Following inhalation, only about 10-20% of inhaled dose reaches the lungs but after nanosizing the drug candidate >50% can be targeted deeper to alveolar region (Bhavna et al, 2009). Several analytical techniques like, ultraviolet spectroscopy (Selek et al, 2003;Shahin et al, 2002), voltammetery (Beltagi et al, 2007), capillary electrophoresis (Boer and Ensing, 1998;Kim et al, 2000), chemiluminescence (Li et al, 2009), high performance liquid chromatography (Chiap et al, 2002;Herring and Johnson, 2000;Jacobson and Peterson, 1994;Reverchon and Porta, 2003;Sagar et al, 1993), LC-electrochemical detection (Edholm et al, 1984;Zhang and Zhang, 2004), LC-tandem MS Fesser et al, 2005), GC-MS (Spisso et al, 2000), and electrospray high-field asymmetric waveform ion mobility spectrometry-mass spectrometry (ESI-FAIMS-MS) (Mie et al, 2008) have been reported in the literature for quantification of TBS; but most of them either employ large sample volumes or have long extraction processes. For pharmacokinetic studies, the most useful bioanalytical method reported is GC-MS (Borgstro¨m et al, 1989;Spisso et al, 2000;Bredberg et al, 1992).…”